Can Augmentin (amoxicillin-clavulanate) 500/125 be given to a 50-year-old adult for treatment of an infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, Augmentin 500/125 mg can be given to a 50-year-old adult for bacterial infections, as it is effective against many common infections, including those caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, as recommended by the British Thoracic Society guideline for bronchiectasis in adults 1. The standard adult dosage is typically one tablet every 8 hours (three times daily) for 7-14 days, depending on the type and severity of infection. This antibiotic combines amoxicillin (500 mg) with clavulanic acid (125 mg), which helps overcome bacterial resistance.

  • The medication should be taken with food to reduce stomach upset.
  • Common side effects include diarrhea, nausea, and skin rash.
  • It's essential to complete the full course of antibiotics even if symptoms improve before finishing.
  • If the patient has a history of penicillin allergy, liver disease, or kidney impairment, they should inform their healthcare provider as dosage adjustments may be necessary. According to the guideline, for Haemophilus influenzae- beta lactamase positive infections, Amoxicillin with clavulanic acid 625 one tablet Three times a day is recommended for 14 days 1. However, the dosage of 500/125 mg is also effective against many other common infections, including sinusitis, bronchitis, pneumonia, ear infections, skin infections, and urinary tract infections, as supported by other studies 1.

From the FDA Drug Label

2.1 Adults The usual adult dose is one 500 mg/125 mg amoxicillin and clavulanate potassium tablet every 12 hours or one 250 mg/125 mg amoxicillin and clavulanate potassium tablet every 8 hours For more severe infections and infections of the respiratory tract, the dose should be one 875 mg/125 mg amoxicillin and clavulanate potassium tablet every 12 hours or one 500 mg/125 mg amoxicillin and clavulanate potassium tablet every 8 hours.

Yes, 500/125 Augmentin can be given to a 50-year-old adult for infection, as the usual adult dose includes one 500 mg/125 mg tablet every 12 hours or every 8 hours, depending on the severity of the infection 2.

From the Research

Augmentin Dosage and Administration

  • The dosage of Augmentin (amoxicillin/clavulanate) for adults is not explicitly stated in the provided studies, but it is mentioned that a pharmacokinetically enhanced tablet dosage form of amoxicillin/clavulanate 2000/125 mg twice daily is available for use in adult respiratory tract infection due to drug-resistant pathogens 3.
  • There is no direct information on the use of 500/125 Augmentin in a 50-year-old adult for infection, but the study suggests that amoxicillin/clavulanate is effective in treating community-acquired respiratory tract infections 3.

Efficacy and Safety of Augmentin

  • Amoxicillin/clavulanate has a well-known safety and tolerance profile, and the two new high-dose formulations are not significantly different from those of conventional formulations 3.
  • The efficacy of amoxicillin/clavulanate in treating infections is high, and it continues to be an important agent in the treatment of community-acquired respiratory tract infections 3.

Resistance and Treatment Failure

  • The emergence of resistant strains, such as S. pneumoniae with elevated penicillin MICs, has been observed in certain geographical areas 3.
  • Previous antimicrobial exposure, particularly to fluoroquinolones or amoxicillin/clavulanate, is associated with the development of amoxicillin/clavulanate resistance in E. coli and K. pneumoniae urinary isolates 4.
  • Treatment failure rates with cefdinir and cephalexin were compared in a retrospective study, and no significant differences were found between the two agents 5.

Combination Therapy

  • Cefixime and amoxicillin/clavulanate combination therapy could be an effective oral outpatient treatment option for ESBL-EC 6.
  • The in vitro synergistic testing of cefixime and amoxicillin/clavulanate was simple and predictive of successful treatment 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.